Predicting Virological Failure with Immunological Criteria in First Line ART Patients in a Resource Poor Setting


Indroduction: National Aids control Organisation in India implementing National AIDS control program uses WHO’s immunological criteria to screen virological failure. Using immunological criteria to detect virological failure has to be assessed. Predicting virological failure with immunological criteria in resource limited settings had low sensitivity. Factors that influence the outcome are studied. Methods: Retrospective study in tertiary care centre for HIV and TB, Chennai, India. Out of 35,044 on ART between January 2008 and September 2009, 452 suspected immunological failures were referred. 273 screened for virological failure. Frequency, sensitivity/specificity, positive/negative predictive values, chi-square test, odds-ratio, independent sample t test for viral load greater than 10,000 and 1000 of each immunological criterion using Epi-Info and SPSS version 19. Results: 172 had virological failure (62.09%). Average age of failed was 37.33. Single criteria’s sensitivity was 60 to 84 for detecting virolological failure. Two or more criteria had specificity 55 to 79. Combination of two or more criteria increased odds ratio for virological failure. Positive predictive value was above 63 for all criteria. PPV was above 80 to the criterion all three positive. Conclusions: ART naive patients with >95% adherence the sensitivity of immunological criteria to detect virological failure is three times than earlier studies. Combination of criteria is more significantly associated with virological failure. Odds ratio doubled for two or more combination of criteria. Immunological criteria is affordable/acceptable for screening virological failure, with adherence > 95% and longer the duration of ART.

Share and Cite:

Raja, K. , Chandrasekar, C. , Krishnarajasekhar, O. , Ravichandran, N. , Kumar, S. , Manoharan, G. and Sharmila, I. (2014) Predicting Virological Failure with Immunological Criteria in First Line ART Patients in a Resource Poor Setting. World Journal of AIDS, 4, 413-421. doi: 10.4236/wja.2014.44049.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] NACO (2011) Patients Alive and on ART.
[2] (2009) Annual Report. Department of AIDS Control, Ministry of Health and Family Welfare.
[3] Hosseinipour, M., van Oosterhout, J., Weigel, R., Mzigangira, D., Saukila, N., Mhango, B., et al., The SAFEST 2 Study Team (2009) Validating Clinical and Immunological Definitions of Antiretroviral Treatment Failure in Malawi. The 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, 22-25 July 2009.
[4] Kumarasamy, N. and Ganguly, M. (2009) Editorial. Indian Journal of Medical Research, 130, 669-670.
[5] NACO (2008) Operational Guidelines for First Line ART Program. Ministry of Health and Family Welfare.
[6] Sungkanuparph, S., Manosuthi, W., Kiertiburanakul, S., Piyavong, B., Chumpathat, N. and Chantratita, W. (2007) Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails. Clinical Infectious Diseases, 44, 447-452.
[7] DART Virology Group and Trial Team (2006) Virological Response to a Triple Nucleoside/Nucleotide Analogue Regimen over 48 Weeks in HIV-1-Infected Adults in Africa. AIDS, 20, 1391-1399.
[8] Hosseinipour, M.C., van Oosterhout, J.J., Weigel, R., Phiri, S., Kamwendo, D., Parkin, N., et al. (2009) The Public Health Approach to Identify Antiretroviral Therapy Failure: High-Level Nucleoside Reverse Transcriptase Inhibitor Resistance among Malawians Failing First-Line Antiretroviral Therapy. AIDS, 23, 1127-1134.
[9] (2008) Helsinki Ethical Declaration. Section B.
[10] (2008) The World Health Organization’s Global Strategy for Prevention and Assessment of HIV Drug Resistance. Antiviral Therapy, 13, 1-13.
[11] Amin, B., Derasari, U., Nihalani, U., Purohit, H., Shevkani, M., Prajapati, S., et al. (2010) ART Center B J Medical College, Ahmedabad, India—Outcome of First Line Antiretroviral Therapy (Art) with Respect to Treatment Failure at ART CENTRE, B. J. Medical College, Civil Hospital. Ahmedabad-Retrovirology, 7, 49.
[12] Rajasekaran, S., Jeyaseelan, L., Vijila, S., Gomathi, C. and Raja, K. (2007) Predictors of Failure of First-Line Antiretroviral Therapy in HIV-Infected Adults: Indian Experience. (GHTM), AIDS, 21, S47-S53.
[13] (2008) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Office of AIDS Research, NIH—A Working Group of the OARAC.
[14] Van Oosterhout, J.J., Brown, L., Weigel, R., Kumwenda, J.J., Mzinganjira, D., Saukila, N., et al. (2009) Diagnosis of Antiretroviral Therapy Failure in Malawi: Poor Performance of Clinical and Immunological WHO Criteria. Tropical Medicine & International Health, 14, 856-861.
[15] Kantor, R., Diero, L., Delong, A., Kamle, L., Muyonga, S., Mambo, F., Walumbe, E., et al. (2009) Misclassification of First-Line Antiretroviral Treatment Failure Based on Immunological Monitoring of HIV Infection in Resource-Limited Settings. Clinical Infectious Diseases, 49, 454-462.
[16] Hosseinpour, M.C. and Schechter, M. (2010) Monitoring Antiretroviral Therapy in Resource-Limited Setting; Balancing Clinical Care, Technology and Human Resource. Current HIV/AIDS Report.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.